Morphological and cytological analyses of PC cells have demonstrated that PKM2 is actively involved in the EMT, a process that facilitates lineage differentiation and contributes to resistance against antiandrogen therapies, ultimately driving tumor progression (78). The gene discussed is PKM; the disease is neoplasm.